同型半胱氨酸测定在脑梗死合并颈动脉病变的应用效果

Determination of Homocysteine in Cerebral Infarction With Carotid Artery Disease

目的研究同型半胱氨酸测定在脑梗死合并颈动脉病变的应用效果。方法选取于2017年3月—2018年3月在我院接受治疗的脑梗死合并颈动脉病变患者78例,为实验组;以及同时期在我院进行健康体检的人员78例,为对照组,两组患者均接受同型半胱氨酸测定。结果实验组患者同型半胱氨酸水平为(36.80±8.49)μmol/L,高于对照组的同型半胱氨酸水平(6.35±1.80)μmol/L,P<0.05,差异存在统计学意义。结论脑梗死及合并颈动脉病变患者,其血清同型半胱氨酸水平上升,所以使用同型半胱氨酸测定可以判断患者是否存在狭窄病变的存在,为患者的临床诊断提供参考。

Objective To study the effect of homocysteine on cerebral infarction with carotid artery lesions. Methods A total of 78 patients with cerebral infarction with carotid artery lesions who were treated in our hospital from March 2017 to March 2018 were selected as the experimental group, and 78 cases who had physical examinations in our hospital during the same period were used as the control group. Both groups were tested for homocysteine. Results The homocysteine level in the experimental group was（36.80 ± 8.49） μmol/L. The homocysteine level was higher than that of the control group（6.35 ± 1.80） μmol/L, P 〈 0.05, the difference was statistically significant. Conclusion For patients with cerebral infarction and carotid artery disease, their serum homocysteine level is increased. Therefore, homocysteine can be used to determine the presence of stenosis and provide reference for clinical diagnosis of patients.